The group's principal activities are to manufacture and market products incorporating a proprietary technology that advances and simplifies biological testing for the life sciences industry. The group's xmap technology allows the luminex 100 system to simultaneously perform up to 100 bioassays on a single drop of fluid by reading biological tests taking place on the surface of microscopic polystyrene beads called microspheres. The xmap technology is currently being used within the various segments of the life sciences industry in the fields of drug discovery, clinical diagnostics, genetic analysis and biomedical research.
